Birthmarks are common and can take a toll on a child’s self-esteem and family dynamics. Birthmarks often go beyond the skin to involve the vascular or nervous systems, may be linked to cancer, and may be just one part of a larger syndrome with whole-body health effects.
PeDRA’s Birthmarks Working Group is made up of physicians and scientists committed to understanding the biology underlying birthmarks and revealing new treatments. Priorities include exploring the use of beta-blockers in high-risk patients, exploring the phenotype-genotype correlation of overgrowth syndromes, and the search for novel genes of medical significance in birthmarks.
The Birthmarks Working Group is chaired by Anita Haggstrom, MD of Indiana University and Megha Tollefson, MD of Mayo Clinic. Contact us if you’re interested in getting involved!
Stay up to date
As research and studies increase in our Birthmarks Working Group, stay informed of relevant updates through a quarterly e-newsletter.